ACKNOWLEDGMENTS
Cancer, Aaron A.R., S. Allen, malaria, Ascada
INFECTIOUS DISEASES, FOUNDER, ALLERGY, MALARIA, ROTH, PAXTON, ROBINSON, CANCER
A. H. Karaba and D. J. Sullivan had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.S. L. Klein, A. L. Cox, A. H. Karaba, and D. J. Sullivan contributed to the conceptualization and design. All authors contributed to acquisition, analysis, or interpretation of the data. A. H. Karaba and D. J. Sullivan drafted the manuscript; all authors critically revised the manuscript for important intellectual content. A. H. Karaba, T. S. Johnston, and D. J. Sullivan conducted the statistical analysis. D. J. Sullivan obtained funding. A. H. Karaba, T. S. Johnston, E. Beck, O. Laeyendecker, and D. J. Sullivan contributed administrative, technical, or material support. A. H. Karaba and D. J. Sullivan supervised the research.This study was funded principally by the U.S. Department of Defense’s (DOD) Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), in collaboration with the Defense Health Agency (DHA) (contract number W911QY2090012), with additional support from Bloomberg Philanthropies, State of Maryland, the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) (3R01AI152078-01S1, K08AI156021, U54CA260491, and R01AI138897), the NIH National Cancer Institute (NCI) (U54CA260491), the NIH National Center for Advancing Translational Sciences (NCATS) (U24TR001609-S3), the Division of Intramural Research NIAID NIH, the Mental Wellness Foundation, the Moriah Fund, Octapharma, the Healthnetwork Foundation, and the Shear Family Foundation. The study sponsors did not contribute to the study design, the collection, analysis, and interpretation of data, or the decision to submit the paper for publication.We report no competing interests to this work. A. H. Karaba reports receiving consulting fees from Roche. D. J. Sullivan reports that he is an AliquantumRx founder and board member with stock options (macrolide for malaria), works for Hemex Health malaria diagnostics consulting, and receives royalties for malaria diagnostic test control standards from Alere—all outside the submitted work.The members of the COVID-10 Serologic Studies Consortium are as follows: Barry R. Meisenberg (Anne Arundel Medical Center), Matthew Abinante (Ascada Research), Kevin Oei (Ascada Research), Yuriko Fukuta (Baylor College of Medicine), Seble Kessaye (MedStar Georgetown University Hospital), Laura L. Hammitt (Johns Hopkins Center for American Indian Health), Catherine G. Sutcliffe (Johns Hopkins Center for American Indian Health), Bryan Lau (Johns Hopkins Bloomberg School of Public Health), Atika Singh (Johns Hopkins Bloomberg School of Public Health), David M. Shade (Johns Hopkins Bloomberg School of Public Health), Stephan Ehrhardt (Johns Hopkins Bloomberg School of Public Health), Sheriza N. Baksh (Johns Hopkins Bloomberg School of Public Health), Andrew Pekosz (Johns Hopkins Bloomberg School of Public Health), Arturo Casadevall (Johns Hopkins Bloomberg School of Public Health), Kelly A Gebo (Johns Hopkins University), Shmuel Shoham (Johns Hopkins University), Evan M. Bloch (Johns Hopkins University), Christi E. Marshall (Johns Hopkins University), Anusha Yarava (Johns Hopkins University), Karen Lane (Johns Hopkins University), Nichol A. McBee (Johns Hopkins University), Amy L. Gawad (Johns Hopkins University), Nicky Karlen (Johns Hopkins University), Daniel E. Ford (Johns Hopkins University), Douglas A. Jabs (Johns Hopkins University), Lawrence J. Appel (Johns Hopkins University), Aaron A.R. Tobian (Johns Hopkins University), Daniel F. Hanley (Johns Hopkins University), Adam C. Levine (Lifespan/Brown University Rhode Island Hospital), Janis E. Blair (Mayo Clinic, Phoenix), Aarthi Shenoy (MedStar Washington Hospital Center), Giselle S. Mosnaim (NorthShore University HealthSystem), Thomas J. Gniadek (NorthShore University HealthSystem), Michael Roth (The Bliss Group), Colin Foster (The Next Practice Group), Judith S. Currier (University of California Los Angeles), Sonya L. Health (University of Alabama at Birmingham), Donald N. Forthal (University of California, Irvine Health), Edward R. Cachay (University of California, San Diego), Elizabeth S. Allen (University of California, San Diego), Moises A. Huaman (University of Cincinnati Medical Center), Jonathan M. Gerber (University of Massachusetts Worcester), Shweta Anjan (University of Miami), Jay S. Raval (University of New Mexico), Martin S. Zand (University of Rochester), Bela Patel (University of Texas Health Science Center at Houston), Emily S. Spivak (University of Utah Health), J. Robinson Singleton (University of Utah Health), Valerie C. Cluzet (Vassar Brothers Medical Center), Daniel Cruser (Vassar Brothers Medical Center), James H. Paxton (Wayne State University), Joann R. Petrini (Western Connecticut Health Network, Danbury Hospital), Patrick B. Broderick (Western Connecticut Health Network, Danbury Hospital), William Rausch (Western Connecticut Health Network, Danbury Hospital), MarieElena Cordisco (Western Connecticut Health Network, Danbury Hospital), Jean Hammel (Western Connecticut Health Network, Norwalk Hospital), Benjamin Greenblatt (Western Connecticut Health Network, Norwalk Hospital).